Antonio Ribeiro

Dr. Antonio Ribeiro serves as a Bioinformatician at the Centre for Genome-Enabled Biology and Medicine (CGEBM) within the School of Medicine, Medical Sciences and Nutrition at the University of Aberdeen. He joined the institution in August 2015, bringing extensive expertise in DNA sequence alignment, SNP calling, and next-generation sequencing data analysis. His technical proficiency spans Bash scripting, Java, and Perl for developing and optimizing bioinformatics pipelines.

Dr. Ribeiro holds an MSc in Computational and Systems Biology from FIOCRUZ-RJ in Brazil, along with specializations in Computer Networks (PUC-Rio) and Information Systems Development (NCE-UFRJ). Prior to his academic career, he accumulated over 20 years of industry experience as a Customer Service Engineer with companies including Nokia-Siemens Networks and Xerox.

His research focuses on advanced bioinformatics applications in microbial genomics, molecular epidemiology, and NGS data analysis. Dr. Ribeiro's work bridges computational methods with medical and biological applications, particularly in bacterial pathogen analysis, antimicrobial resistance studies, and genomic variation detection. His technical background enables sophisticated analysis of complex genomic datasets across diverse biological contexts.

Analysis of his publication history reveals a strong trajectory in computational genomics with increasing focus on medical applications. His recent work (2023-2025) centers on molecular epidemiology of bacterial bloodstream infections, antimicrobial resistance mechanisms, and clinical applications of genomic analysis. Earlier publications (2012-2016) demonstrate foundational work in NGS data processing, SNP validation, and bioinformatics tool development.

Dr. Ribeiro's technical expertise in processing and analyzing NGS data using both third-party open-source tools and custom scripts positions him at the intersection of computational science and biological research. His work supports critical medical research through advanced genomic analysis capabilities, contributing to understanding of bacterial pathogens, antimicrobial resistance, and genomic variation.